Concepedia

Publication | Closed Access

A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days

DOI

81

Citations

6

References

1989

Year

PatrickJ. Creaven, DeanE. Brenner, J. Wayne Cowens, RobertP. Huben, RichardM. Wolf, Hiroshi Takita, SusanG. Arbuck, MohamedS. Razack, AprilD. Proefrock
Cancer Chemotherapy and Pharmacology

References

YearCitations

Page 1